NCPDP Foundation Awards $100,000 to Support Real-Time Prescription Benefit (RTPB) Standard Projects at DrFirst and Johns Hopkins Medicine

NCPDP’s Real-Time Prescription Benefit (RTPB) Standard’s Transparency of Prescription Drug Coverage and Out-of-Pocket Costs To Speed Time to Therapy and Improve Adherence SCOTTSDALE, ARIZ. (PRWEB) DECEMBER 02, 2019 The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has approved $100,000 in funding[…]

Read more

AP_SUNY PDK 3.5a Drives Design for Manufacturability with First Lumerical INTERCONNECT Statistical Compact Model Library

20+ statistical models support PIC yield analysis ALBANY, N.Y. (PRWEB) DECEMBER 03, 2019 Analog Photonics (AP), SUNY Poly and Lumerical Inc., a leading developer of photonic design and simulation tools, announce the release of AP_SUNY Process Design Kit (PDK) v3.5 Compact Model Library sponsored by AIM Photonics. The PDK Component Library,[…]

Read more

Rubikloud’s latest artificial intelligence-enabled solution helps retailers optimize promotions to maximize sales and reduce stockouts

The latest in Rubikloud’s lineup of AI-enabled solutions increases the effectiveness of promotions, optimizes category spend, improves forecast accuracy and saves valuable time TORONTO, ONTARIO (PRWEB) DECEMBER 03, 2019 Rubikloud, the maker of world-leading artificial intelligence (AI) and machine learning technology, is increasing its capabilities to help retailers and consumer packaged[…]

Read more

Life Science Logistics Begins Construction on Second Indianapolis-Area Facility, Doubles Cold Chain Storage to Meet Demand

Expansion creates 50 new jobs as pharma, medical device demand booms INDIANAPOLIS (PRWEB) DECEMBER 03, 2019 As the pharmaceutical and medical device market continues to demand greater FDA-regulated, temperature-controlled storage and distribution, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced it has begun construction[…]

Read more

Catalent to Partner with Ethicann on New Fast-Dissolve Cannabinoid-Based Treatment for Multiple Sclerosis Spasticity

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it has entered into a partnership with Ethicann Pharmaceuticals Inc. (“Ethicann”), a Calgary-based pharmaceutical company using botanically sourced cannabinoid oils to formulate prescription drugs. The[…]

Read more